Pharmacokinetic Interaction Between Lopinavir/r and Amprenavir in Salvage Therapy

This publication has 11 references indexed in Scilit:

• Interactions among Drugs for HIV and Opportunistic Infections
  New England Journal of Medicine, 2001
• Effect of reduced-dose amprenavir in combination with lopinavir on plasma levels of amprenavir in patients infected with HIV
  Clinical Therapeutics, 2001
• Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral Dosing
  Antimicrobial Agents and Chemotherapy, 2001
• Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors
  AIDS, 2000
• Drug interactions of HIV protease inhibitors.
  Drug Safety, 1999
• Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV Infection
  Clinical Pharmacokinetics, 1999
• Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1998
• Ritonavir
  Clinical Pharmacokinetics, 1998
• Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir
  British Journal of Clinical Pharmacology, 1997
• Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir
  Antimicrobial Agents and Chemotherapy, 1997